Dongwha Pharm, Active Community... Stock Price Up 14.54%.

At this time, posts about Dongwha Pharm are rapidly increasing on portals and securities communities. Today, foreigners have net sold 57,138 shares of Dongwha Pharm, while institutions have net bought 48,000 shares, according to provisional data. Dongwha Pharm is known as a manufacturer and seller of pharmaceuticals (such as Gas Hwal Myeong Su and Fusidin).

As of 11:30 AM on the 5th, Dongwha Pharm's stock price is 13,000 KRW, up 14.54% from the previous day, with a trading volume of 4,854,461 shares, which is 269.35% of the average trading volume on the 5th. On May 27, Dongwha Pharm became a market issue with the news of the imminent Phase 2 clinical trial of a COVID-19 treatment, causing a sharp rise.

In addition to Dongwha Pharm, posts by investors are also rapidly increasing regarding Korean Air (003490), Taepyeongyang Mulsan (007980), and SNK (950180).

※Source: AI Investment Assistant AI Rassiro

※ This article was generated in real-time by an article auto-generation algorithm jointly developed by Asia Economy and financial AI specialist company Thinkpool.

This content was produced with the assistance of AI translation services.